Author Response: Prescribed Drug Use and Aneurysmal Subarachnoid Hemorrhage Incidence: A Drug-Wide Association Study

Jos P Kanning, Shahab Abtahi, Olaf H Klungel, Ynte M Ruigrok

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

We thank Drs. Cameron and Siegler for their thoughtful letter on our article.1 We think that the first point on the increased risk of aneurysmal subarachnoid hemorrhage (aSAH) with prochlorperazine use, and the possible explanation with sentinel headaches, concerns protopathic bias, or reverse causality. This bias occurs when the early signs or symptoms of a still undiagnosed latent outcome lead to prescription of a medicine and then to a flawed association between the prescribed medicine and that outcome, when it is finally diagnosed.2 This usually happens with chronic outcomes that have a long latency period, such as cancers.3

Original languageEnglish
Article numbere210035
JournalNeurology
Volume104
Issue number12
Early online date22 May 2025
DOIs
Publication statusPublished - 24 Jun 2025

Bibliographical note

Publisher Copyright:
© 2025 American Academy of Neurology.

Fingerprint

Dive into the research topics of 'Author Response: Prescribed Drug Use and Aneurysmal Subarachnoid Hemorrhage Incidence: A Drug-Wide Association Study'. Together they form a unique fingerprint.

Cite this